Mankind Pharma Q1 Profit Falls, Revenue Jumps

  Published 8 months ago

Mankind Pharma's Q1FY26 net profit fell 18.1% YoY, while revenue surged 24.5% with strong export and segment growth.

  • EBITDA rose 26% YoY to ₹847.6 crore; margin improved slightly to 23.7% on better operational efficiency.
  • Export revenue jumped 81.1% YoY to ₹469 crore, driven by BSV consolidation and base business expansion.
  • Consumer healthcare grew 15% YoY; e-commerce share rose to 11% with strong brand performance across key products.
You might like these

India, UK Sign Landmark Trade Deal

Ashok Leyland Shares Surge on Rate Cut & Upgrade

Kitex Launches 'Little Star' in India

Adani Wilmar Q1 Revenue Hits Record

Glenmark Launches Halaven Generic in US

CFF Fluid Signs Sonar Deal

Banks Cautious Ahead of RBI VRRR

News that matters the most ⚡